Analyst Ratings For MacroGenics (NASDAQ:MGNX)
Today, BTIG Research reiterated its Buy rating on MacroGenics (NASDAQ:MGNX) with a price target of $28.00.
Some recent analyst ratings include
- 1/23/2018-BTIG Research Reiterated Rating of Buy.
- 12/11/2017-Raymond James Financial Reiterated Rating of Buy.
- 10/25/2017-Cowen Reiterated Rating of Buy.
- 9/12/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 9/11/2017-Wedbush Reiterated Rating of Outperform.
- 9/1/2017-SunTrust Banks Reiterated Rating of Buy.
Recent Insider Trading Activity For MacroGenics (NASDAQ:MGNX)
MacroGenics (NASDAQ:MGNX) has insider ownership of 8.30% and institutional ownership of 85.78%.
- On 1/17/2018 Jon Marc Wigginton, SVP, sold 5,000 with an average share price of $20.00 per share and the total transaction amounting to $100,000.00.
- On 11/21/2017 Jon Marc Wigginton, SVP, sold 5,000 with an average share price of $20.00 per share and the total transaction amounting to $100,000.00.
- On 10/25/2017 Jon Marc Wigginton, SVP, sold 10,000 with an average share price of $20.00 per share and the total transaction amounting to $200,000.00.
- On 6/5/2017 Jon Marc Wigginton, SVP, sold 5,000 with an average share price of $20.00 per share and the total transaction amounting to $100,000.00.
- On 4/19/2017 Jon Marc Wigginton, SVP, sold 15,000 with an average share price of $20.00 per share and the total transaction amounting to $300,000.00.
- On 10/3/2016 Jon Marc Wigginton, CMO, sold 10,000 with an average share price of $29.34 per share and the total transaction amounting to $293,400.00.
- On 10/3/2016 Lynn Cilinski, VP, sold 6,231 with an average share price of $29.28 per share and the total transaction amounting to $182,443.68.
Recent Trading Activity for MacroGenics (NASDAQ:MGNX)
Shares of MacroGenics closed the previous trading session at 19.67 up +0.25 1.29% with 19.540000915527344 shares trading hands.